Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development
Cardiovascular Research · 2023
DOI: 10.1093/cvr/cvad143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2023. Verfasst von Fitzwilliam Seibertz und 24 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttin…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Induced Pluripotent Stem Cells, Atrial Remodeling. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, German Center for Cardiovascular Research, BMBF.
Abstract (Originalsprache)
Aims
Atrial fibrillation (AF) is associated with tachycardia-induced cellular electrophysiology alterations which promote AF chronification and treatment resistance. Development of novel antiarrhythmic therapies is hampered by the absence of scalable experimental human models that reflect AF-associated electrical remodelling. Therefore, we aimed to assess if AF-associated remodelling of cellular electrophysiology can be simulated in human atrial-like cardiomyocytes derived from induced pluripotent stem cells in the presence of retinoic acid (iPSC-aCM), and atrial-engineered human myocardium (aEHM) under short term (24 h) and chronic (7 days) tachypacing (TP). Methods and results First, 24-h electrical pacing at 3 Hz was used to investigate whether AF-associated remodelling in iPSC-aCM and aEHM would ensue. Compared to controls (24 h, 1 Hz pacing) TP-stimulated iPSC-aCM presented classical hallmarks of AF-associated remodelling: (i) decreased L-type Ca2+ current (ICa,L) and (ii) impaired activation of acetylcholine-activated inward-rectifier K+ current (IK,ACh). This resulted in action potential shortening and an absent response to the M-receptor agonist carbachol in both iPSC-aCM and aEHM subjected to TP. Accordingly, mRNA expression of the channel-subunit Kir3.4 was reduced. Selective IK,ACh blockade with tertiapin reduced basal inward-rectifier K+ current only in iPSC-aCM subjected to TP, thereby unmasking an agonist-independent constitutively active IK,ACh. To allow for long-term TP, we developed iPSC-aCM and aEHM expressing the light-gated ion-channel f-Chrimson. The same hallmarks of AF-associated remodelling were observed after optical-TP. In addition, continuous TP (7 days) led to (i) increased amplitude of inward-rectifier K+ current (IK1), (ii) hyperpolarization of the resting membrane potential, (iii) increased action potential-amplitude and upstroke velocity as well as (iv) reversibly impaired contractile function in aEHM.
Conclusions
Classical hallmarks of AF-associated remodelling were mimicked through TP of iPSC-aCM and aEHM. The use of the ultrafast f-Chrimson depolarizing ion channel allowed us to model the time-dependence of AF-associated remodelling in vitro for the first time. The observation of electrical remodelling with associated reversible contractile dysfunction offers a novel platform for human-centric discovery of antiarrhythmic therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany.
- DZHK (German Center for Cardiovascular Research), partner site Göttingen, Germany.
- Cluster of Excellence 'Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells' (MBExC), University of Göttingen, Göttingen, Germany.
- Department of Cardiothoracic and Vascular Surgery, Georg-August-University Göttingen, Göttingen, Germany.
- Nanion Technologies GmbH, Munich, Germany.
- Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Georg-August University Göttingen, Germany.
ORCID-Profile: Fitzwilliam Seibertz, Fiona Popp, Markus Rapedius, Richard Solano, Tobias Bruegmann, Ingo Kutschka, Katrin Streckfuss-Bömeke, George Kensah, Lukas Cyganek, Wolfram H Zimmermann, Niels Voigt
Förderung
- Deutsche Forschungsgemeinschaft
- German Center for Cardiovascular Research
- BMBF
- Göttingen Promotionskolleg für Medizinstudierende
- Jacob-Henle-Programm
- Else-Kröner-Fresenius-Stiftung
- DZHK
- Fondation Leducq
Zitieren
APA
Seibertz, F., Rubio, T., Springer, R., Popp, F., Ritter, M., Liutkute, A., Bartelt, L., Stelzer, L., Haghighi, F., Pietras, J., Windel, H., Pedrosa, N. D. I., Rapedius, M., Doering, Y., Solano, R., Hindmarsh, R., Shi, R., Tiburcy, M., Bruegmann, T., …, & Voigt, N. (2023). Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development. Cardiovascular Research. https://doi.org/10.1093/cvr/cvad143
Vancouver
Seibertz F, Rubio T, Springer R, Popp F, Ritter M, Liutkute A, et al. Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development. Cardiovascular Research. 2023. doi:10.1093/cvr/cvad143
BibTeX
@article{Seibertz2023,
author = {Seibertz, Fitzwilliam and Rubio, Tony and Springer, Robin and Popp, Fiona and Ritter, Melanie and Liutkute, Aiste and Bartelt, Lena and Stelzer, Lea and Haghighi, Fereshteh and Pietras, Jan and Windel, Hendrik and Pedrosa, Núria Díaz I and Rapedius, Markus and Doering, Yannic and Solano, Richard and Hindmarsh, Robin and Shi, Runzhu and Tiburcy, Malte and Bruegmann, Tobias and Kutschka, Ingo and Streckfuss-Bömeke, Katrin and Kensah, George and Cyganek, Lukas and Zimmermann, Wolfram H and Voigt, Niels},
title = {Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development},
journal = {Cardiovascular Research},
year = {2023},
doi = {10.1093/cvr/cvad143}
}
EUVIMED